Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 26, 2021; 9(30): 9090-9100
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9090
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9090
Table 3 Meta-analysis for association of breast cancer susceptibility gene 1 expression with survival of resected esophageal squamous cell carcinoma patients
Analysis | No. of studies | HR (95%CI) | Log-rank P value | I2 (%) | P value |
Overall survival | 10 | 1.60 (1.25-2.05) | < 0.001 | 0 | 0.794 |
Country | |||||
Non-Asian countries | 4 | 1.57 (1.15-2.15) | 0.005 | 0.0 | 0.798 |
Asian countries | 6 | 1.66 (1.12-2.45) | 0.011 | 7.5 | 0.495 |
Disease-free survival | 9 | 1.78 (1.42-2.23) | < 0.001 | 0.0 | 0.781 |
Country | |||||
Non-Asian countries | 3 | 1.58 (1.13-2.20) | 0.007 | 22.3 | 0.276 |
Asian countries | 6 | 1.97 (1.44-2.69) | < 0.001 | 0.0 | 0.936 |
- Citation: Gao Y, Luo XD, Yang XL, Tu D. Clinical significance of breast cancer susceptibility gene 1 expression in resected non-small cell lung cancer: A meta-analysis . World J Clin Cases 2021; 9(30): 9090-9100
- URL: https://www.wjgnet.com/2307-8960/full/v9/i30/9090.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i30.9090